diabetes

10 Events that Rattled Medtech in 1Q18
Medical Devices and Diagnostics Industry
Sat, 03/31/18 - 10:10 am
devices
InMode
Votiva
JNJ
diabetes
LifeScan
Orthotaxy
robotic surgery
Abbott Labs
HeartMate 3
Medtronic
Guardian Sensor 3
Edwards Lifesciences
Centera valve
SFC Fluidics
EOFlow Co
type 1 diabetes
Boston Scientific
FDA
duodenoscope
PENTAX
Fujifilm
Olympus
Theranos
Elizabeth Holmes
Sanofi seeks to restore leadership in diabetes treatments
GoinPharma
Sat, 03/31/18 - 09:59 am
Sanofi
diabetes
sotagliflozin
Half-off sale at Eli Lilly as drug rebating climbs to 51% in 2017
Fierce Pharma
Sat, 03/31/18 - 09:56 am
Eli Lilly
drug rebates
drug pricing
diabetes
FDA committee backs Senseonics’ implantable continuous glucose monitor
Drug Delivery Business News
Fri, 03/30/18 - 09:19 am
FDA
Senseonics
devices
diabetes
implantable continuous glucose monitoring
blood glucose monitoring
Eversense
Sanofi’s high-capacity insulin pen wins FDA nod
Drug Delivery Business News
Tue, 03/27/18 - 11:05 am
Sanofi
insulin
insulin pen
FDA
devices
Toujeo
diabetes
FDA approves label update to Novo Nordisk’s Tresiba diabetes drug
Drug Delivery Business News
Mon, 03/26/18 - 10:39 pm
FDA
Novo Nordisk
diabetes
Tresiba
labeling
insulin degludec
Japan approves Novo Nordisk’s once-weekly Type II diabetes drug
Drug Delivery Business News
Fri, 03/23/18 - 09:45 am
Japan
Novo Nordisk
diabetes
type 2 diabetes
Ozempic
AstraZeneca touts a fresh cut of Farxiga data targeting diabetes patients with chronic kidney disease
Endpoints
Tue, 03/20/18 - 09:38 am
AstraZeneca
Farxiga
diabetes
chronic kidney disease
Orthopedic Device Market Gains Momentum: 3 Stocks in Focus
Yahoo/Zacks.com
Mon, 03/19/18 - 11:55 am
devices
Orthopedics
Stryker
Orthofix
JNJ
robotic surgery
diabetes
regulatory
J&J says offered $2.1 billion for LifeScan diabetes unit
Yahoo/Reuters
Fri, 03/16/18 - 09:26 am
JNJ
devices
diabetes
M&A
LifeScan
ACC: Waiting on the FDA's heart-helping verdict, J&J touts more positive CV data for Invokana
Fierce Pharma
Sun, 03/11/18 - 06:10 pm
ACC
FDA
Invokana
diabetes
Five Events That Disrupted the Diabetes Market
Medical Devices and Diagnostics Industry
Fri, 03/9/18 - 10:47 am
diabetes
devices
DexCom
blood glucose monitoring
Google
Verily
JNJ
Medtronic
MiniMed 670G
artificial pancreas
Abbott Labs
FDA
FreeStyle Libre Flash
Lilly, Boehringer add two Jardiance heart failure studies to examine effects on exercise
Fierce Pharma
Wed, 03/7/18 - 12:00 pm
Eli Lilly
Boehringer Ingelheim
Jardiance
heart failure
exercise
diabetes
GLP-1 Drug Class May Continue to Drive Growth for Novo Nordisk
Market Realist
Mon, 03/5/18 - 09:24 am
Novo Nordisk
GLP-1 agonist
diabetes
Victoza
Diabetic Retinopathy Could Soon be Diagnosed by AI System
Xtalks
Tue, 02/27/18 - 10:42 pm
diabetes
diabetic retinopathy
artificial intelligence
diagnostics
IDx
Medtronic thinks these clinics could be the future of diabetes care – here’s why
Drug Delivery Business News
Tue, 02/27/18 - 06:50 pm
Medtronic
diabetes
devices
Diabeter
value-based care
It’s Medtronic vs. Abbott in Battle to Disrupt Diabetes Care
Medical Devices and Diagnostics Industry
Mon, 02/26/18 - 11:06 pm
Medtronic
Abbott Labs
diabetes
devices
Guardian Sensor 3
FreeStyle Libre
Lilly touts Ph3 data for once-weekly Type II diabetes medication
Drug Delivery Business News
Mon, 02/26/18 - 07:27 pm
Eli Lilly
diabetes
clinical trials
Trulicity
In a turf war with Eli Lilly, Novo Nordisk steps off with positive PhIII for its challenging oral GLP-1 drug
Endpoints
Thu, 02/22/18 - 09:12 am
Novo Nordisk
Eli Lilly
diabetes
clinical trials
semaglutide
Trulicity
Lilly, Livongo team up for real-world diabetes research, aiming for better results in an outcomes-oriented market
Fierce Pharma
Mon, 02/12/18 - 04:31 pm
Eli Lilly
Livongo
diabetes
R&D

Pages